Summary

Market Overview
The Global Urinalysis Market was valued at USD 4.39 billion in 2024 and is projected to reach USD 6.84 billion by 2030, growing at a CAGR of 7.67%. This growth is largely driven by the increasing prevalence of chronic diseases such as diabetes and kidney disorders. Urinalysis is a diagnostic method that examines the physical, chemical, and microscopic properties of urine to detect and monitor a range of health conditions, including urinary tract infections, kidney disease, and diabetes. As a non-invasive and informative testing approach, urinalysis is gaining prominence in early diagnosis and disease management. Additionally, rising public awareness about urinary and kidney health, combined with increased government support and healthcare investment, is enhancing accessibility and fueling demand across both developed and developing markets.
Key Market Drivers
Rising Prevalence of Chronic Diseases
The global rise in chronic conditions—particularly diabetes and chronic kidney disease (CKD)—is a major factor accelerating the growth of the urinalysis market. Urinalysis is a non-invasive, affordable diagnostic tool that plays a critical role in early detection, ongoing monitoring, and treatment planning for these diseases.
According to the World Health Organization (WHO), the global population aged 60 and above is expected to reach 2.1 billion by 2050, significantly increasing the incidence of age-related illnesses such as diabetes and CKD. The International Diabetes Federation noted that 537 million adults were living with diabetes in 2021, with projections indicating this figure will rise to 643 million by 2030. Urinalysis enables detection of biomarkers like glucose, ketones, and protein in urine, making it essential for effective management and timely intervention.
Key Market Challenges
Regulatory Compliance and Quality Control
The urinalysis market faces significant regulatory and quality assurance challenges. Manufacturers must meet stringent requirements imposed by bodies such as the FDA and EMA, which involve comprehensive product testing, documentation, and adherence to Good Manufacturing Practices (GMP). These compliance processes can be time-consuming and financially demanding.
Ensuring consistency in product performance across production batches is crucial, as any variation can compromise diagnostic accuracy. This necessitates rigorous quality control mechanisms and ongoing surveillance. For example, under the FDA’s Medical Device Reporting (MDR) regulation, manufacturers are required to report device-related adverse events, ensuring constant monitoring and safety validation. These high standards increase the operational burden, potentially limiting market entry for smaller players and slowing innovation due to the associated costs and complexities.
Key Market Trends
Shift Towards Point-of-Care Testing
A major trend in the urinalysis market is the transition toward point-of-care testing (POCT), driven by the need for rapid diagnostics and decentralized healthcare services. POCT enables immediate testing and results interpretation at the site of care, which enhances clinical responsiveness and patient outcomes.
Urinalysis has emerged as a key area within POCT, thanks to the development of portable, easy-to-use devices that can be deployed in clinics, emergency rooms, and even at home. These devices offer fast analysis of urine parameters like glucose, protein, and leukocytes, facilitating prompt diagnosis and treatment.
Government support has further strengthened this trend. For instance, the Centers for Medicare & Medicaid Services (CMS) in the U.S. have introduced reimbursement policies that encourage POCT use in primary care. During health crises such as the COVID-19 pandemic, regulatory bodies also accelerated the approval of POCT devices to expand diagnostic capacity, underscoring the growing role of POCT in the future of healthcare.
Key Market Players
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Abbott Laboratories
• Cardinal Health Inc.
• Danaher Corporation
• Sysmex Corporation
• Quidel Corporation
• Becton, Dickinson & Company
• Bio-Rad Laboratories Inc.
• EKF Diagnostics Holdings plc
Report Scope:
In this report, the Global Urinalysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Urinalysis Market, By Product:
o Consumables
o Instruments
• Urinalysis Market, By Test Type:
o Pregnancy & Fertility Tests
o Biochemical Urinalysis
o Sediment Urinalysis
• Urinalysis Market, By Application:
o Disease Screening
o Pregnancy & Fertility
• Urinalysis Market, By End User:
o Diagnostic Laboratories
o Hospitals & Clinics
o Home Care Settings
o Research Laboratories & Institutes
• Urinalysis Market, By Region:
o North America
§ United States
§ Mexico
§ Canada
o Europe
§ France
§ Germany
§ United Kingdom
§ Italy
§ Spain
o Asia-Pacific
§ China
§ India
§ South Korea
§ Japan
§ Australia
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East and Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Urinalysis Market.
Available Customizations:
Global Urinalysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. By Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered.
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Urinalysis Market Outlook.
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Consumables & Instruments)
5.2.2. By Test Type (Pregnancy & Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis)
5.2.3. By Application (Disease Screening and Pregnancy & Fertility)
5.2.4. By End user (Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes)
5.2.5. By Company (2024)
5.2.6. By Region
5.3. Market Map
6. Asia-Pacific Urinalysis Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Test Type
6.2.3. By Application
6.2.4. By End user
6.2.5. By Country
6.3. Asia-Pacific: Country Analysis
6.3.1. China Urinalysis Market Outlook.
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Test Type
6.3.1.2.3. By Application
6.3.1.2.4. By End user
6.3.2. India Urinalysis Market Outlook.
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Test Type
6.3.2.2.3. By Application
6.3.2.2.4. By End user
6.3.3. South Korea Urinalysis Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Test Type
6.3.3.2.3. By Application
6.3.3.2.4. By End user
6.3.4. Japan Urinalysis Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Product
6.3.4.2.2. By Test Type
6.3.4.2.3. By Application
6.3.4.2.4. By End user
6.3.5. Australia Urinalysis Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Product
6.3.5.2.2. By Test Type
6.3.5.2.3. By Application
6.3.5.2.4. By End user
7. Europe Urinalysis Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Test Type
7.2.3. By Application
7.2.4. By End user
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Urinalysis Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Test Type
7.3.1.2.3. By Application
7.3.1.2.4. By End user
7.3.2. Germany Urinalysis Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Test Type
7.3.2.2.3. By Application
7.3.2.2.4. By End user
7.3.3. United Kingdom Urinalysis Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Test Type
7.3.3.2.3. By Application
7.3.3.2.4. By End user
7.3.4. Italy Urinalysis Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Test Type
7.3.4.2.3. By Application
7.3.4.2.4. By End user
7.3.5. Spain Urinalysis Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Test Type
7.3.5.2.3. By Application
7.3.5.2.4. By End user
8. North America Urinalysis Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Test Type
8.2.3. By Application
8.2.4. By End user
8.2.5. By Country
8.3. North America: Country Analysis
8.3.1. United States Urinalysis Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Test Type
8.3.1.2.3. By Application
8.3.1.2.4. By End user
8.3.2. Mexico Urinalysis Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Test Type
8.3.2.2.3. By Application
8.3.2.2.4. By End user
8.3.3. Canada Urinalysis Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Test Type
8.3.3.2.3. By Application
8.3.3.2.4. By End user
9. South America Urinalysis Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Test Type
9.2.3. By Application
9.2.4. By End user
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Urinalysis Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Test Type
9.3.1.2.3. By Application
9.3.1.2.4. By End user
9.3.2. Argentina Urinalysis Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Test Type
9.3.2.2.3. By Application
9.3.2.2.4. By End user
9.3.3. Colombia Urinalysis Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Test Type
9.3.3.2.3. By Application
9.3.3.2.4. By End user
10. Middle East and Africa Urinalysis Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Test Type
10.2.3. By Application
10.2.4. By End user
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Urinalysis Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Test Type
10.3.1.2.3. By Application
10.3.1.2.4. By End user
10.3.2. Saudi Arabia Urinalysis Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Test Type
10.3.2.2.3. By Application
10.3.2.2.4. By End user
10.3.3. UAE Urinalysis Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Test Type
10.3.3.2.3. By Application
10.3.3.2.4. By End user
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. By Product Developments
13. Porters Five Forces Analysis
1.1. Competition in the Industry
1.2. Potential of New Entrants
1.3. Power of Suppliers
1.4. Power of Customers
1.5. Threat of Substitute Products/Services
14. Urinalysis Market: SWOT Analysis
15. Competitive Landscape
15.1. F. Hoffmann-La Roche Ltd
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. By Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Siemens Healthineers AG
15.3. Abbott Laboratories
15.4. Cardinal Health Inc.
15.5. Danaher Corporation
15.6. Sysmex Corporation
15.7. Quidel Corporation
15.8. Becton, Dickinson & Company
15.9. Bio-Rad Laboratories Inc.
15.10. EKF Diagnostics Holdings plc
16. Strategic Recommendations
17. About Us & Disclaimer